CCRM
Vishal Prasher currently works as an Operations Lead at CCRM, specializing in cell and gene therapy for cancer treatment with a focus on T cell receptor-based therapy. Prior to this role, Vishal held positions as a Manufacturing Technician at Resilience Biotechnologies Inc, and as a Production Technician at Therapure Biopharma Inc. Vishal also has experience working as a Customer Service Representative at Domino's. Education-wise, Vishal holds a Master's degree in Pharmacology from Centennial College and a Bachelor's degree in Pharmacy from Punjab Technical University. Additionally, Vishal conducted thesis work on Urolithiasis while serving as a Research Scholar at Punjab Technical University.
CCRM
1 followers
Regenerative Medicine (RM), which aims to harness the power of stem cells, biomaterials and molecules to repair, regenerate or replace diseased cells, tissues and organs, has the promise to treat, manage and perhaps cure some of the most devastating and costly diseases in the world today. Many new and potentially life-changing RM-based treatments never reach patients because they are not successfully moved from the laboratory to a stage where they can be used in medicine. In order to fulfill RM’s promise to treat the many diseases affecting our population, a world-renowned group of stem cell scientists and engineers have come together to form CCRM, a leader in developing and commercializing regenerative medicine and cell therapy technologies. CCRM formally launched on June 14, 2011. CCRM supports the development and commercialization of regenerative medicines and associated enabling technologies, with a specific focus on cell and gene therapy.